Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
25,001 - 50,000 - Monthly Reach
Unique listeners across all episodes (30 days)
75,001 - 150,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 14 epsHost
Recent guests
No guests detected in recent episodes.
Recent episodes
Silent Slip: How Medications Are Fueling Falls in Our Elderly
May 5, 2026
5m 07s
The Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study
May 3, 2026
5m 21s
Antidepressant Withdrawal: 50% of Long-Term Users Suffer? Shocking JAMA Study vs Real-World Reality Exposed
Apr 27, 2026
10m 19s
Metabolic Brake or Muscle Catalyst? The Pharmacokinetics of GLP-1 Muscle Loss
Apr 26, 2026
4m 46s
Ibogaine: Miracle Cure or Medical Gamble? The Truth Behind a Controversial Psychedelic
Apr 20, 2026
7m 24s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 5/5/26 |  Silent Slip: How Medications Are Fueling Falls in Our Elderly✨ | medicationsfalls+4 | — | Circle Of Insight Productions | — | medicationsfalls+5 | — | 5m 07s | |
| 5/3/26 | The Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study✨ | Emergency MedicineClinical Markers+5 | — | Circle Of Insight ProductionsThe Dangerous Tetrad: Mastering the Fatal Signs of Rigidity and Fever -case study | — | Dangerous Tetradrigidity+7 | — | 5m 21s | |
| 4/27/26 | Antidepressant Withdrawal: 50% of Long-Term Users Suffer? Shocking JAMA Study vs Real-World Reality Exposed✨ | antidepressant withdrawalSSRIs+4 | — | JAMA Psychiatry | — | antidepressant withdrawalSSRIs+5 | — | 10m 19s | |
| 4/26/26 | Metabolic Brake or Muscle Catalyst? The Pharmacokinetics of GLP-1 Muscle Loss✨ | pharmacologymuscle loss+4 | — | GLP-1 receptor agonistssemaglutide+3 | — | GLP-1muscle loss+5 | — | 4m 46s | |
| 4/20/26 | Ibogaine: Miracle Cure or Medical Gamble? The Truth Behind a Controversial Psychedelic✨ | ibogainepsychedelic treatment+6 | — | — | — | addiction sciencemental health+2 | — | 7m 24s | |
| 4/20/26 | Low-Dose Methamphetamine Neuroprotection: What the Studies Actually Show✨ | methamphetamineneuroprotection+2 | — | — | — | low-doseneuroprotection+2 | — | 3m 10s | |
| 4/19/26 | The Messy Truth About Antidepressants: Benefits, Risks, and the Limits of the Evidence✨ | antidepressantsdepression+2 | — | — | — | placebo responsepublication bias+3 | — | 9m 05s | |
| 4/11/26 | Why One ADHD Medication Hits Kids So Differently — And How Genetics Can Help✨ | ADHDmedication+2 | — | ADHD medication | — | ADHD medicationgenetic factors+2 | — | 1m 38s | |
| 1/6/26 | Artificial intelligence begins prescribing medications in Utah✨ | artificial intelligencemedications+2 | — | — | Utah | AIprescription+1 | — | 1m 33s | |
| 10/19/25 | Marijuana and emphysema✨ | Marijuanaemphysema+2 | — | — | — | cannabislung health+1 | — | 1m 40s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 9/28/25 | Ketamine and neurotoxicity✨ | ketamineneurotoxicity+2 | — | — | — | ketamineneurotoxicity+2 | — | 2m 08s | |
| 9/14/25 | New study on lithium✨ | lithiummental health+2 | — | — | — | studymedication+2 | — | 1m 55s | |
| 8/24/25 | Is low-dose quetiapine safe for insomnia?✨ | quetiapineinsomnia+1 | — | quetiapine | — | low-dosesleep disorders+1 | — | 1m 29s | |
| 8/17/25 | How assessments can increase antidepressant prescriptions✨ | antidepressantsassessments+1 | — | — | — | prescriptionmental health assessment+1 | — | 1m 28s | |
| 8/3/25 | Saffron being studied for insomnia | No description provided. | 1m 23s | ||||||
| 7/30/25 | Centanafadine is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) under development for ADHD. | No description provided. | 2m 01s | ||||||
| 7/27/25 | IS THERE A DIFFERENCE BETWEEN THE INJECTABLE OR ORAL NALTREXONE AND TREATMENT | No description provided. | 1m 20s | ||||||
| 7/13/25 | A LOOK AT BIRTH CONTROL TO DEPRESSION TO ANTIDEPRESSANTS | No description provided. | 2m 55s | ||||||
| 7/6/25 | PRAMIPEXOLE FOR TREATMENT RESISTANT DEPRESSION | No description provided. | 1m 41s | ||||||
| 6/29/25 | ABILIFY COULD LEAD TO GAMBLING ADDICTION | No description provided. | 2m 04s | ||||||
| 6/22/25 | VARENICLINE POSSIBLY COULD HELP WITH ALCOHOL USE DISORDER | No description provided. | 2m 03s | ||||||
| 6/15/25 | ANTIDEPRESSANTS DURING PREGNANCY MAY ALTER FETAL DEVELOPMENT | No description provided. | 2m 53s | ||||||
| 6/15/25 | LEVETIRACETAM POSSIBLE ADJUNCT FOR BIPOLAR MANIA | No description provided. | 1m 23s | ||||||
| 6/8/25 | A STUDY ON ANTIPSYCHOTICS | No description provided. | 3m 24s | ||||||
| 6/1/25 | TOM WOLF DISCUSSES HIS OVERCOMING OF ADDICTION AND HOMELESSNESS | No description provided. | 1h 06m 03s | ||||||
Showing 25 of 423
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.